FILTER
Prikaži samo sadržaje koji zadovoljavaju:
objavljeni u periodu:
na jeziku:
hrvatski engleski
sadrže pojam:

Advisory company in favour of partnership between Pliva and Actavis

ZAGREB, April 20 (Hina) - The Quaestus investment fund, which gathersnine successful Croatian companies, has assessed that a possiblepartnership between the leading Croatian pharmaceutical company Plivaand Iceland's Actavis is the best solution for Pliva shareholders,employees and the national economy.
ZAGREB, April 20 (Hina) - The Quaestus investment fund, which gathers nine successful Croatian companies, has assessed that a possible partnership between the leading Croatian pharmaceutical company Pliva and Iceland's Actavis is the best solution for Pliva shareholders, employees and the national economy.

Quaestus Private Equity Partners Ltd. ("Quaestus"), a Croatian advisory company managing first Croatian private equity venture ("The Partnership") on behalf Croatian institutional investors, on Thursday expressed willingness to invest more Croatian capital in that partnership.

Quaestus believes that a business strategy offered by Actavis guarantees more jobs in Croatia and the enhanced exploitation of Pliva's research and development as well as production capacity in the country.

According to a press release the fund issued today, the readiness of the Icelandic company to quote its own shares on a Croatian stock exchange market gives additional guarantees for all Croatian participants and presents a strong contribution to the development of the Croatian capital market.

Earlier on Thursday, Actavis announced its improved preliminary proposal to Pliva, offering 630 kuna per share in cash.

The first preliminary offer of 570 kuna per share was dismissed by Pliva's management as unattractive and unfriendly.

VEZANE OBJAVE

An unhandled error has occurred. Reload 🗙